Related Experiment Videos
The allure of 'ALUR'
M Nagasaka1, V W Zhu2, S-H I Ou2
1Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, USA.
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib.
Lung cancer (Amsterdam, Netherlands)·2017
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SKYSCRAPER-03: A Phase III Study of Tiragolumab Plus Atezolizumab Versus Durvalumab in Locally Advanced, Unresectable, Stage III NSCLC After Platinum-Based Concurrent Chemoradiation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A Multimodal Deep Learning Model for Preoperative Prediction of Postoperative Complications in Gastric Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Irving Roy Rathgeb, Jr., MD (1913-1943). Physician, Surgeon, and Member of the United States Army Medical Corps.
Journal of community health·2026
[An inspired and wandering researcher: Charles-Édouard Brown-Séquard (1817-1894)].
Biologie aujourd'hui·2026
Being Seen to Care: Photographs, Audiences, and the Swiss Medical Mission in Colonial Mozambique at the Turn of the Twentieth Century.
Bulletin of the history of medicine·2026
Charm rescattering in B 0 → K 0 ℓ ¯ ℓ : an improved analysis.
The European physical journal. C, Particles and fields·2025